BIG news! Thrilled to share that @GoHumanFirst has been acquired by @ICONplc to build the world’s first precision measures platform. Together with @MAPI_global, we’ll unlock the next chapter of digital biomarkers and COAs! statnews.com/2024/02/29/icon…

This year, our team’s work grew the evidence in Atlas by more than 70%! We’re so proud of the skills on our team and their dedication to our mission of unlocking better research for all humans, faster, by enabling #PrecisionMeasures in clinical research.

This year, we saw an exciting shift in clinical trial strategy. Pharma companies are taking a refreshed look at ways to incorporate the patient voice & leverage tech to accelerate drug development. Read more about the trend towards #precisionhealth gohumanfirst.com/posts/year-…

Showcasing our latest product features at the @CNSSummit AI Demo #CNSSummit2023

Join HumanFirst @SyneosHealth @Bristol_Myers @JNJInnovMed today @CNSSummit 2PM spotlight session on AI-Powered Precision Health to hear how experts are using precision measures to bring patient-centered treatments to market faster and more efficiently. #CNSSummit2023

Proud to be one of the initial supporting corporations on Mural Health's effort to eliminate a barrier that prevents the ~90 million Americans who rely on a social-welfare program from enrolling in or completing a #clinicaltrial. Learn how you can support: world.einnews.com/pr_news/66…

Investing in AI? Digital biomarkers are a tried and true innovation that has been leveraging AI & ML for years. Learn how your precision measurement strategy can benefit from #AI via consistently validated, effective and safe #digitalbiomarkers. gohumanfirst.com/posts/teste…

A Precision Measures approach means first identifying the measures that matter to patients, then matching them to the right technologies. See some of HumanFirst's latest research around comparing actively collected & passively monitored COAs gohumanfirst.com/posts/human…

On November 8, @AndreaCoravos will be speaking at the Digital Implementation Summit about broadening use cases for clinical trial endpoints. Come say hi to HumanFirst and learn how we're helping pharma make fast, accurate protocol design decisions digitalimplementation.panago…

Meet us in Boston! HumanFirst CEO @AndreaCoravos will be speaking about AI applications in precision health @CNSSummit. Learn more about HumanFirst's work in this space gohumanfirst.com/posts/press… #CNSSummit2023

Now, Atlas users can even more easily compare DHTs and eCOAs across measures and weigh the supporting evidence. Learn more about the latest workflow features in the Atlas Platform gohumanfirst.com/posts/make-… #biomarkers

Just how many pharmaceutical orgs have invested in digital endpoints for their clinical trials? The newly-released analysis from HumanFirst reveals numbers behind the trend. Read the analysis: gohumanfirst.com/posts/digit… #digitalhealth

🆕 Make fast, confident decisions with the new Projects and Lists features in the Atlas Platform #clinicalresearch gohumanfirst.com/posts/make-…

In partnership w/ MAPI Research Trust, @SyneosHealth, @RochePharmaUK & @genentech, we've built + validated the 1st tool-agnostic framework to select measures that matter to patients. Read how this ontology can help in your #clinicaltrials gohumanfirst.com/posts/human…

Big News! We just launched a first-of-its-kind Precision Measures enterprise platform designed to help #biotech & #pharma accelerate #clinicaltrials. Save time & costs by incorporating patient-centric measures & validated tech into your research. Read more gohumanfirst.com/posts/press…

Speaking at the #ClinicalTrialsInnovationSummit, hosted by @Roche @PanAgoraPharma, HumanFirst spoke about using technology to enable patient-centric, evidence-based drug development #ai gohumanfirst.com/solutions/p…

@AndreaCoravos will be speaking at #digitalbiomarkers West today on increasing adoption of decentralized clinical trials digbiomarkerswest.com/agenda…

Which TAs rose to the top? - Neurology/Psychiatry - Cardiology - Endocrinology - Pulmonary - Hematology/Oncology - MSK/Rheumatology - Infectious Diseases - Nephrology - Gastroenterology - Pediatrics/Neonatology - Women's Health - Dermatology - Opthamology/ENT

For today’s drop, we cut the data by high-level therapeutic areas to show: 📈 Which areas see the highest volume of research 🐣 Which digital biomarkers are in later vs. earlier stages of development